Pinned Tweet
Replying to @BuchholzLab_TUD
@BuchholzLab_TUD new manuscript alert! 🚨 This time with me as a first author! 🥳 Read the thread bellow for a short summary of the work! 🧵
academic.oup.com/nar/advance…
Milica Jelicic retweeted
I’m not easily shook these days but the number of people who think the appropriate punishment for not following a masked federal agent’s orders is assassination is rather shocking
My friends came to this amazing idea to share the story of how our friendship grew even stronger in spite all of the struggles of academic journey.
If you are interested check out our story! 🤩🤩🤩
doi.org/10.1038/d41586-024-0…
Check out our story! From inseparable undergrads in Belgrade to PhDs scattered across the globe, FFDS (Four Friends Doing Science) kept us inspiring each other, no matter the distance.
Can you guess who’s who😆?
@BorisStojilkovc @Jacafaca_ @TismaMilos
1
160
Milica Jelicic retweeted
Jel i vi imate na instagramu ove apoliticne koji i dalje cepaju selfije i čaše dobrog vina kao da zivimo u epizodi seks i grada a ne u paklu
So proud of my friend showing once more that dedication and hard work pays off! 🥳🤩
Today, I was honored to receive the Best Thesis Award from @frsFNRS at the ED15 Doctoral School in Belgium. I am truly grateful for everything that @LalouxLab have done for me. I proudly carry the "Laloux-mni" name with me! #foreverabdellofan!
4
225
👏🏼👏🏼👏🏼+1
Out today in @NAR_Open from @cees_dekker lab!!
*DNA supercoiling enhances DNA condensation by ParB proteins*
doi.org/10.1093/nar/gkae936
Together with @Aless322 (and @Gruber_Lausanne ) we show the interaction between partition complex proteins (ParB) and supercoiled DNA!
88
👏🏼👏🏼👏🏼
We are happy to share our latest paper “A unified mechanism for PARP inhibitor-induced PARP1 chromatin retention at DNA damage sites in living cells”, out today in @CellReports. #PARP1 #PARPinhibitor #GenomicStability
Hopefully not a boring thread ↓
cell.com/cell-reports/fullte…
1
115
Milica Jelicic retweeted
Moderna revenue drops from $1.9b to $167m - and they, in turn, drop a major gene editing partnership.
DESPITE being able to make a CRISPR cure in 2 weeks (yes, you read that right).
They cannot make money on these - under the current system.
As I wrote in 2021 (pubmed 34710352):
Milica Jelicic retweeted
💡Exciting news, tomorrow at the #CRISPRMED24 in Copenhagen, catch @DuranSueruen’s presentation about his remarkable work on the directed evolution of highly efficient and specific Miniature CRISPR-Cas systems and new TadA variants🧬. Don’t miss out!🌟@CrisprMedicine
The final version of the #CRISPRMED24 Program is now available crisprmedicinenews.com/filea…
Meet here the speakers, poster presenters and the panelists
#crisprmedicinenews #crisprmedicine
Milica Jelicic retweeted
Heute ist #RareDiseaseDay2024: Eine Erkrankung ist selten, wenn sie weniger als 5 von 10.000 Menschen betrifft. Es gibt jedoch mehr als 8.000 seltene Erkrankungen, vier Millionen Menschen in Dtl. sind betroffen. Dr. Franziska Rillig aus dem #UKEHamburg: t1p.de/mlvyy
Milica Jelicic retweeted
Cells are fast and crowded places. Numbers help us make sense of them.
Here are five of my favorite "bionumbers."
1. ATP synthase spins 134 times/second. That is much faster than the propeller on most piston airplanes, and about half the r.p.m. of a Boeing 737 jet engine.
🥳👏🏼
🎉I am thrilled to announce that my PhD thesis work got published in @NatureBiotech today! Grateful to all co-authors from @BuchholzLab_TUD and @seamlesstx.🧬We developed zinc finger DNA-binding dependent site-specific recombinases.
nature.com/articles/s41587-0… See the thread below:
4
142
🥳🥳🥳🥰🥰🥰
🧬 Exciting news! Don't miss our latest publication introducing DEQSeq, a groundbreaking nanopore sequencing method for genome editing enzyme selection from evolved variants. Great job, @LukasTSchmitt, and all the co-authors!👏🏻 #DEQSeq #GenomeEditing genomebiology.biomedcentral.…
187
🚨New paper alert! We present here the DEQSeq method for screening thousands variants of DNA editing enzymes at once. 🧬 So proud to be a part of this story! 🥰🥳🤩
Excited to share my first last Author paper. Out now in @GenomeBiology
We @BuchholzLab_TUD report two new methods. To evolve CRISPR-Cas systems (CaSLiDE) and to screen thousands of variants at once (DEQSeq)
Thanks to the amazing team of co-authors!
genomebiology.biomedcentral.…
Congrats to my best friend @TismaMilos for becoming my #NARbuddy 💪🏼😍 one more paper on his record, I am sooo proud! 🤩🥲 He and @JovanaKaljevic really are the biggest ParB fans! 😉
And yet another #CDlab paper published, in @NAR_Open!
academic.oup.com/nar/advance…
Here @TismaMilos and coauthors showed how bacterial ParB proteins makes a condensate on DNA which is essential for chromosome segregation.
Great collaboration with @Gruber_Lausanne and @Dmichiel1 labs
6
304
Milica Jelicic retweeted
Open joint postdoc position!
Come join my group and @EustermannLab at @EMBLHeidelberg as a postdoctoral researcher. Apply by Nov. 8: embl.org/jobs/position/HD024…
So proud to be a part of this group of amazing people 😍🤩 Can’t wait to witness more of their outstanding achievements in the future! 4FDS now and always 🤍
The four of us studied and supported each other from the first exam 2013! Now we are at 2/4 Ph.D done! I can't wait to create more memories and celebrate our achievements in the future! Four Friends Doing Science (4FDS) forever🤍 @BorisStojilkovc @Jacafaca_ @TismaMilos
🥳🥳🥳
I am thrilled to see our paper published! Thanks to my fantastic mentor @LalouxLab (I will miss us working together) and our collaborators @Tung_BK_Le. Special thanks to my @CoralieTesseur - who made the revision process 3x more fun! Enjoy!
1
153
Milica Jelicic retweeted
The first dosing of a patient in the U.S. with a base-edited therapeutic has taken place. Congratulations to the @BeamTx team on achieving this milestone. 🍻
First patient dosed with Beam-201! 💫 globenewswire.com/news-relea…
Milica Jelicic retweeted
When the lab crew comes together in a Kochloft, magic happens!👨🍳🥘 Food, lab mates, fun - a perfect recipe for an unforgettable experience!🍽️👩🔬#FoodieScientists #ExperimentalFeast

































